ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3

Biochemical and Biophysical Research Communications

Volumn 314, Issue 1, 2004, Pages 97-103

  Nojiri, Shunsuke ^a   Joh, Takashi ^a   Miura, Yutaka ^a   Sakata, Nobuo ^b   Nomura, Tomoyuki ^a   Nakao, Haruhisa ^a   Sobue, Satoshi ^a   Ohara, Hirotaka ^a   Asai, Kiyofumi ^a   Ito, Makoto ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AT MOTIF BINDING FACTOR 1; BINDING PROTEIN; INTERLEUKIN 6; PROTEIN INHIBITOR OF ACTIVATED STAT3; STAT3 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; YEAST;

EID: 9144256378     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.054     Document Type: Article

References (23)

1. Morinaga T., Yasuda H., Hashimoto T., Higashio K., Tamaoki T. A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers. Mol. Cell. Biol. 11:1991;6041-6049.
2. Miura Y., Tam T., Ido A., Morinaga T., Miki T., Hashimoto T., Tamaoki T. Cloning and characterization of an ATBF1 isoform that expresses in a neuronal differentiation-dependent manner. J. Biol. Chem. 270:1995;26840-26848.
3. Kataoka H., Miura Y., Joh T., Seno K., Tada T., Tamaoki T., Nakabayashi H., Kawaguchi M., Asai K., Kato T., Itoh M. Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1. Oncogene. 20:2001;869-873.
4. Kataoka H., Joh T., Miura Y., Tamaoki T., Senoo K., Ohara H., Nomura T., Tada T., Asai K., Kato T., Itoh M. AT motif binding factor 1-A (ATBF1-A) negatively regulates transcription of the aminopeptidase N gene in the crypt-villus axis of small intestine. Biochem. Biophys. Res. Commun. 267:2000;91-95.
5. Watanabe M., Miura Y., Ido A., Sakai M., Nishi S., Inoue Y., Hashimoto T., Tamaoki T. Developmental changes in expression of the ATBF1 transcription factor gene. Brain Res. Mol. Brain Res. 42:1996;344-349.
6. Ido A., Miura Y., Watanabe M., Sakai M., Inoue Y., Miki T., Hashimoto T., Morinaga T., Nishi S., Tamaoki T. Cloning of the cDNA encoding the mouse ATBF1 transcription factor. Gene. 168:1996;227-231.
7. Berry F.B., Miura Y., Mihara K., Kaspar P., Sakata N., Hashimoto-Tamaoki T., Tamaoki T. Positive and negative regulation of myogenic differentiation of C2C12 cells by isoforms of the multiple homeodomain zinc finger transcription factor ATBF1. J. Biol. Chem. 276:2001;25057-25065.
8. Kaspar P., Dvorakova M., Kralova J., Pajer P., Kozmik Z., Dvorak M. Myb-interacting protein, ATBF1, represses transcriptional activity of Myb oncoprotein. J. Biol. Chem. 274:1999;14422-14428.
9. Shuai K. The STAT family of proteins in cytokine signaling. Prog. Biophys. Mol. Biol. 71:1999;405-422.
10. Schindler C., Darnell J.E. Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:1995;621-651.
11. Darnell J.E. STATs and gene regulation. Science. 277:1997;1630-1635.
12. Heinrich P.C., Behrmann I., Muller-Newen G., Schaper F., Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334:1998;297-314.
13. Zhong Z., Wen Z., Darnell J.E.J. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 264:1994;95-98.
14. Kamohara Y., Sugiyama N., Mizuguchi T., Inderbitzin D., Lilja H., Middleton Y., Neuman T., Demetriou A.A., Rozga J. Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure. Biochem. Biophys. Res. Commun. 273:2000;129-135.
15. Kotaja N., Vihinen M., Palvimo J.J., Janne O.A. Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling. J. Biol. Chem. 277:2002;17781-17788.
16. Kotaja N., Karvonen U., Janne O.A., Palvimo J.J. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22:2002;5222-5234.
17. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S.M., Ariga H. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J. Biol. Chem. 276:2001;37556-37563.
18. Levy C., Nechushtan H., Razin E. A new role for the STAT3 inhibitor, PIAS3. J. Biol. Chem. 277:2002;1962-1966.
19. Rodel B., Tavassoli K., Karsunky H., Schmidt T., Bachmann M., Schaper F., Heinrich P., Shuai K., Elsasser H.P., Moroy T. The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO J. 19:2000;5845-5855.
20. Nakagawa K., Yokosawa H. PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. FEBS Lett. 530:2002;204-208.
21. Kordula T., Rydel R., Brigham E., Horn F., Heinrich P., Travis J. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes. J. Biol. Chem. 273:1998;4112-4118.
22. Chung C.D., Liao J., Liu B., Rao X., Jay P., Berta P., Shuai K. Specific inhibition of Stat3 signal transduction by PIAS3. Science. 278:1997;1803-1805.
23. Rozga J. Hepatocyte proliferation in health and in liver failure. Med. Sci. Monit. 8:2002;32-38.